Skip to main
GRAL

GRAIL Inc (GRAL) Stock Forecast & Price Target

GRAIL Inc (GRAL) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

GRAIL Inc has experienced a substantial share appreciation of nearly 90% in the past month, driven by optimistic developments from the PATHFINDER 2 ESMO data readout and the potential positive outcome of the NHS Galleri trial. The company’s Total Addressable Market (TAM) analysis indicates a significant revenue opportunity, estimated at approximately $3.7 billion in the UK by 2026, growing to $4.0 billion by 2035, further supported by partnerships that enhance access to this market. Additionally, GRAIL's pending $400 million infusion into its balance sheet bolsters its financial position, despite lingering uncertainties surrounding Medicare reimbursement and regulatory approvals.

Bears say

GRAIL Inc. has consistently reported significant net losses since its inception and projects ongoing financial deficits as it continues to pursue regulatory approvals and expand its operations. Key risks impacting the company's outlook include potential delays in legislative support for reimbursements of its mult-cancer early detection (MCED) tests, adoption challenges for this novel technology, and competitive pressure from larger diagnostic firms with established infrastructure. Additionally, rising selling, general, and administrative expenses related to the growth of Galleri volumes and uncertainty regarding timely clinical study results further complicate GRAIL's commercial viability and financing prospects.

GRAIL Inc (GRAL) has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GRAIL Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GRAIL Inc (GRAL) Forecast

Analysts have given GRAIL Inc (GRAL) a Buy based on their latest research and market trends.

According to 3 analysts, GRAIL Inc (GRAL) has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $105, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $105, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GRAIL Inc (GRAL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.